Issued Patents 2020
Showing 1–4 of 4 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10765711 | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy | Stewart Shuman, Jedd D. Wolchok, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2020-09-08 |
| 10736962 | Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors | Stewart Shuman, Jedd D. Wolchok, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2020-08-11 |
| 10639366 | Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors | Stewart Shuman, Jedd D. Wolchok, Taha Merghoub, Peihong Dai, Weiyi Wang | 2020-05-05 |
| 10548930 | Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors | Jedd D. Wolchok, Taha Merghoub, Stewart Shuman, Peihong Dai, Weiyi Wang | 2020-02-04 |